Superficial Radiotherapy with the SRT-100™: The Non-Surgical Choice for Basal Cell Carcinoma Treatment

Superficial Radiotherapy with the SRT-100™: The Non-Surgical Choice for Basal Cell Carcinoma Treatment

Basal Cell Carcinoma Treatment

Each year, more than 2.5 million new cases of basal cell carcinoma are diagnosed in the U.S. It is the most frequently occurring form of skin cancer.

Basal cell cancer can be caused by intense sun exposure as well as cumulative sun exposure over time. It is an abnormal, uncontrolled growth or lesion on the skin and can look like an open sore, red patch, pink growth, shiny bump or scar.

Unlike some forms of cancer, basal cell carcinoma rarely spreads beyond the original tumor sight, nor is it likely to be life threatening. It can, however, become disfiguring if not treated promptly.

Basal Cell Skin Cancer Treatment

Patients dealing with basal cell cancer have several treatment options available to them, including: Mohs micrographic surgery, excisional surgery, electro surgery, cryosurgery and laser surgery. But these treatments all have one thing in common: the word surgery.

Patients now have another option: Superficial Radiotherapy, or SRT — a non-surgical treatment for basal cell carcinoma. It is the non-surgical choice for removing non-melanoma skin cancer.

The SRT-100™ by Sensus Healthcare delivers a precise, calibrated, low dose of Superficial Radiotherapy that effectively destroys basal cell cancers. No anesthesia, cutting or stitching required. It is painless and causes no bleeding. With this treatment, there is no risk of infection or scarring and no need for future reconstructive plastic surgery. The SRT-100™ treats basal cell carcinoma, and patients have no downtime or lifestyle restrictions following treatment.

The U.S. Food and Drug Administration has approved the SRT-100™ as a safe and effective treatment for basal cell skin cancer. The procedure takes just minutes in a physician’s office and offers the same cure rates as surgical treatments, destroying skin cancer without any collateral damage to healthy skin cells. It is ideal for patients with health risks that prevent them from undergoing surgical treatment, or patients who wish to avoid the pain and scarring associated with surgery.

If you have been diagnosed with basal cell carcinoma, ask Dr. Michael Gold and his staff of skincare experts about the SRT-100™ to treat your skin cancer.

The blog post is credited to Sensus Healthcare.